UnitedHealth (UNH) Recovery Continues -- Beats Earnings, Raises Outlook[Stocks](https://moneymorning.com/category/article/stocks/) # UnitedHealth (UNH) Recovery Continues -- Beats Earnings, Raises Outlook  by Rich Duprey  October 28, 2025  Share it: The largest U.S. health insurer, **UnitedHealth Group** ( [UNH](https://moneymorning.com/stocks/unh/)), delivered a strong third-quarter performance this morning, underscoring its ongoing recovery from earlier challenges. The company reported revenues of $113.2 billion, a 12% increase year-over-year, driven by robust growth in its UnitedHealthcare and Optum segments. Earnings came in at $2.59 per share, with adjusted EPS at $2.92, beating analyst expectations. Cash flows from operations reached $5.9 billion, or 2.3 times net income. Bolstering investor confidence, UNH raised its full-year 2025 outlook, projecting net earnings of at least $14.90 per share and adjusted earnings of at least $16.25 per share. This beat arrives amid UNH's rebound from a turbulent period, including Medicare funding cuts and elevated medical costs, which pushed shares below $250 in August – a massive discount for a blue-chip stock. Investors who hesitated missed a prime opportunity to snag this [quality dividend payer at bargain prices](https://moneymorning.com/2025/07/25/bad-news-bear-stock-unh-tumbles-after-confirming-doj-probe/). However, with shares now up about 56% from those lows, UNH remains undervalued and worth buying.  What makes UNH a standout? As a diversified healthcare giant, it serves over 50 million domestic consumers through UnitedHealthcare's benefits plans and leverages Optum's tech-driven services for payers, providers, and consumers. Optum's revenues grew 8% to $69.2 billion in Q3, fueled by pharmacy services and analytics. The company's resilient business model, with a 3.8% operating margin and consistent dividend growth (yielding around 2.4%), positions it for durable expansion. Despite pressures like a 89.9% medical care ratio, UNH's focus on cost control and innovation – evident in serving 96 million Optum Health consumers – drives long-term value. At current levels, UNH trades at a forward P/E of about 18x, below its historical average and that of its peers, offering a compelling entry point. With accelerating growth eyed for 2026, this recovery story is far from over. **Beat the market, without relying on brokers or biased institutions.** Email(Required) Comments This field is for validation purposes and should be left unchanged. Subscribe By submitting your email address, you will receive a free subscription to _Money Morning!_ and occasional special offers from us and our affiliates. You can unsubscribe at any time and we encourage you to read more about our [Privacy Policy](https://moneymorning.com/privacy/). ## One moment, please: Processing your submission ###### More Trending Stories from Money Morning - [$10,000 Invested in MercadoLibre 5 Years Ago Would Be How Much?!](https://moneymorning.com/2026/02/27/10000-invested-in-mercadolibre-5-years-ago-would-be-how-much/) - [Is a Buyout the Hope PayPal Investors Have Been Waiting For?](https://moneymorning.com/2026/02/27/is-a-buyout-the-hope-paypal-investors-have-been-waiting-for/) - [Here's Why ACM Research Is a Buy Despite Its Earnings Miss](https://moneymorning.com/2026/02/27/heres-why-acm-research-is-a-buy-despite-earnings/) - [Axon Enterprise Stuns the Market With Huge Q4 Earnings Beat](https://moneymorning.com/2026/02/27/axon-enterprise-stuns-the-market-with-huge-q4-earnings-beat/) - [Anthropic Mauls CrowdStrike Again. Here's Why the Cybersecurity Stock Is a Buy](https://moneymorning.com/2026/02/25/anthropic-mauls-crowdstrike-again-heres-why-the-cybersecurity-stock-is-a-buy/) Share it: ### Popular Articles ###### [Here's Why ACM Research Is a Buy Despite Its Earnings Miss](https://moneymorning.com/2026/03/01/why-acm-research-is-a-buy-despite-earnings/) March 1, 2026 ###### [$10,000 Invested in MercadoLibre 5 Years Ago Would Be How Much?!](https://moneymorning.com/2026/02/27/10000-invested-in-mercadolibre-5-years-ago-would-be-how-much/) February 27, 2026 ###### [Here's Why ACM Research Is a Buy Despite Its Earnings Miss](https://moneymorning.com/2026/02/27/heres-why-acm-research-is-a-buy-despite-earnings/) February 27, 2026 ###### [Axon Enterprise Stuns the Market With Huge Q4 Earnings Beat](https://moneymorning.com/2026/02/27/axon-enterprise-stuns-the-market-with-huge-q4-earnings-beat/) February 27, 2026 Notifications reCAPTCHA Recaptcha requires verification. [Privacy](https://www.google.com/intl/en/policies/privacy/) \- [Terms](https://www.google.com/intl/en/policies/terms/) protected by **reCAPTCHA** [Privacy](https://www.google.com/intl/en/policies/privacy/) \- [Terms](https://www.google.com/intl/en/policies/terms/)